Merck
CN

Deep brain optogenetics without intracranial surgery.

Nature biotechnology (2020-10-07)
Ritchie Chen, Felicity Gore, Quynh-Anh Nguyen, Charu Ramakrishnan, Sneha Patel, Soo Hyun Kim, Misha Raffiee, Yoon Seok Kim, Brian Hsueh, Esther Krook-Magnusson, Ivan Soltesz, Karl Deisseroth
ABSTRACT

Achieving temporally precise, noninvasive control over specific neural cell types in the deep brain would advance the study of nervous system function. Here we use the potent channelrhodopsin ChRmine to achieve transcranial photoactivation of defined neural circuits, including midbrain and brainstem structures, at unprecedented depths of up to 7 mm with millisecond precision. Using systemic viral delivery of ChRmine, we demonstrate behavioral modulation without surgery, enabling implant-free deep brain optogenetics.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Kainic acid monohydrate, ≥99% (TLC)